U.S. Semiconductors Stock News

NasdaqGS:SONO
NasdaqGS:SONOConsumer Durables

Sonos (SONO) Q1 EPS Breakthrough Challenges Longstanding Profitability Concerns

Sonos (SONO) opened its 2026 financial year with Q1 revenue of US$545.7 million and basic EPS of US$0.78, alongside net income of US$93.8 million. This set a clear marker after last year’s mixed quarters. The company’s quarterly revenue moved from US$550.9 million in Q1 2025 to US$545.7 million in Q1 2026, while basic EPS shifted from US$0.41 to US$0.78 over the same period. These figures highlight how near term profitability is intersecting with longer term expectations around growth and...
NYSE:NABL
NYSE:NABLSoftware

Can N-able’s (NABL) New Agentic AI Push It Into the Cyber Resilience Big Leagues?

N-able, Inc. recently announced enhanced AI capabilities across its cyber resilience platform, applying agentic AI to endpoint management, security operations, and data protection for small- and medium-sized businesses. By harnessing telemetry from more than 11 million managed endpoints and over 25,000 technology service providers, N-able is turning vast operational data into unified, AI-driven tools that aim to reduce complexity while strengthening cyber defenses. We’ll now examine how...
NasdaqGS:EBC
NasdaqGS:EBCBanks

Do Eastern Bankshares' (EBC) 2025 Results Recast Its Capital Return Strategy Or Reinforce The Status Quo?

Eastern Bankshares, Inc. recently reported full-year 2025 results showing net interest income of US$828.6 million and net income of US$88.2 million, alongside a regular quarterly dividend of US$0.13 per share payable on March 20, 2026 to shareholders of record on March 6, 2026. The company also completed a share repurchase of 3,100,000 shares for US$55.4 million and reported quarterly net charge-offs of US$9.8 million, or 0.18% of average total loans, highlighting its ongoing capital...
NasdaqGS:BELF.A
NasdaqGS:BELF.AElectronic

Evaluating Bel Fuse (BELF.A) After Strong Recent Share Price Momentum

Why Bel Fuse is on investors’ radar today Bel Fuse (BELF.A) has been drawing attention after a strong run in recent months, with the stock showing a one-month return of 24.5% and a three-month return of 37.7%. See our latest analysis for Bel Fuse. That recent momentum, with a 24.5% 30 day share price return and 37.7% 90 day share price return, sits alongside a very large 5 year total shareholder return. This suggests that investors have been steadily reassessing Bel Fuse’s growth prospects...
NYSE:SCHW
NYSE:SCHWCapital Markets

Is It Too Late To Consider Charles Schwab (SCHW) After A 99% Five-Year Return?

If you are wondering whether Charles Schwab still offers good value at its current share price, or if most of the upside has already been priced in, this article breaks down what the numbers are actually saying about the stock today. The share price recently closed at US$103.88, with returns of 0.4% over 7 days, 0.1% over 30 days, 2.3% year to date, 28.4% over 1 year, 34.6% over 3 years and 99.1% over 5 years. This naturally raises questions about where valuation stands now. Recent headlines...
NYSE:CNMD
NYSE:CNMDMedical Equipment

A Look At CONMED (CNMD) Valuation After Earnings And Growth In Key Surgical Segments

CONMED (CNMD) shares were in focus after the company reported fourth quarter and full year 2025 results, issued 2026 revenue guidance, and highlighted momentum in orthopedics and high growth surgical segments. See our latest analysis for CONMED. At a share price of US$39.93, CONMED has seen short term momentum pick up, with a 1 day share price return of 2.94% and 7 day share price return of 3.21%. However, the 1 year total shareholder return of 45.45% and 5 year total shareholder return of...
NYSE:AFG
NYSE:AFGInsurance

American Financial Group Margin Softness Challenges Bullish Profitability Narratives

American Financial Group (AFG) has wrapped up FY 2025 with fourth quarter revenue of US$2.2b and basic EPS of US$3.59, alongside net income of US$299m. Its trailing twelve month figures sit at US$8.2b of revenue and EPS of US$10.08 on net income of US$842m. Over recent periods, quarterly revenue has ranged from US$1.8b to US$2.3b, while basic EPS has moved between roughly US$1.84 and US$3.59. This gives investors a clear view of how earnings track alongside top line shifts. With a trailing...
NasdaqGS:DLO
NasdaqGS:DLODiversified Financial

Assessing DLocal (DLO) Valuation As Its Emerging Markets Payments Platform Extends Reach And Product Offering

DLocal (DLO) is back in focus after highlighting the reach of its emerging market payments platform across more than 40 countries, alongside new BNPL, tokenized payment and stablecoin offerings. Fresh partnerships with Western Union, Google, Capitec, Bolt, Fireblocks and Grey are widening its network and giving investors more detail on how DLocal is trying to deepen its role in cross border payment flows. See our latest analysis for DLocal. Despite the product rollouts and new partnerships,...
NasdaqGS:ACLS
NasdaqGS:ACLSSemiconductor

A Look At Axcelis Technologies (ACLS) Valuation After Recent Mixed Share Price Performance

Why Axcelis Technologies is on investors’ radar today Axcelis Technologies (ACLS) has drawn fresh attention after a period of mixed share performance, with a 1 day decline, a weaker past week and month, but a slightly positive past 3 months. For investors, that kind of uneven return profile often raises questions about how the current share price lines up with Axcelis’s actual business results and long term prospects in semiconductor equipment. See our latest analysis for Axcelis...
NYSE:BHE
NYSE:BHEElectronic

Benchmark Electronics (BHE) Margin Compression Reinforces Bearish Narratives Despite Revenue Progress

Benchmark Electronics (NYSE:BHE) has wrapped up FY 2025 with fourth quarter revenue of US$704.3 million and basic EPS of US$0.17, alongside net income excluding extra items of US$6.0 million, putting the spotlight firmly on how efficiently that top line is translating into profit. The company has seen quarterly revenue move from US$656.9 million and EPS of US$0.51 in Q4 2024 to US$704.3 million and EPS of US$0.17 in Q4 2025, with trailing twelve month EPS at US$0.69, which sets up a close...
NasdaqGS:TPG
NasdaqGS:TPGCapital Markets

Is TPG’s (TPG) Tech-Driven Insurance Push Reframing Its Core Value-Creation Playbook?

TPG has launched Third Wave Insurance, a new technology-focused retail insurance brokerage led by industry veteran Brian Bair, alongside its first partnership with Palmer & Cay, a long-established independent brokerage in the Southeastern U.S. that will keep its brand and leadership under CEO Jack Cay. This move highlights TPG’s push to build a modern insurance distribution platform by combining digital tools with Palmer & Cay’s longstanding regional franchise and sector expertise. Next,...
NasdaqCM:EVLV
NasdaqCM:EVLVElectronic

Evolv School Security Expansion And What It May Mean For EVLV Stock

Evolv Technologies Holdings expanded its partnership with East Baton Rouge Parish Schools to deploy additional AI-based weapons detection systems across more campuses. The rollout extends the use of Evolv’s security technology across the Louisiana school district as part of its broader safety initiatives. Evolv Technologies Holdings, listed as NasdaqCM:EVLV, is drawing fresh attention as its AI-based weapons detection systems reach more K 12 schools in East Baton Rouge Parish. The company’s...
NYSE:ENVA
NYSE:ENVAConsumer Finance

A Look At Enova International (ENVA) Valuation After Strong 2025 Earnings Results

Enova International (ENVA) is back in focus after reporting fourth quarter and full year 2025 results. Management pointed to strong small business and consumer lending activity and targeted marketing that supported revenue and net income. See our latest analysis for Enova International. The earnings release and recent share repurchases have come after a strong run, with Enova International’s 90 day share price return of 26.75% and a 1 year total shareholder return of 35.72%, while shorter...
NasdaqGS:DFTX
NasdaqGS:DFTXPharmaceuticals

Is Adsett’s Board Appointment And Breakthrough DT120 Status Altering The Investment Case For Definium Therapeutics (DFTX)?

Definium Therapeutics, Inc. recently appointed veteran biopharmaceutical executive Roger Adsett to its Board of Directors, effective January 29, 2025, while analysts initiated positive coverage emphasizing its late-stage brain health pipeline, including FDA Breakthrough Therapy Designation for DT120 in generalized anxiety disorder. Adsett’s extensive track record in global drug launches and building commercial organizations at companies such as Insmed, Shire, and AstraZeneca adds experienced...